Lodinews.com

default avatar
Welcome to the site! Login or Signup below.
|
||
Logout|My Dashboard

Tim and Debbie Daugherty: Working Together to Help Battle Prostate Cancer

Print
Font Size:
Default font size
Larger font size

Posted: Wednesday, December 5, 2012 10:00 pm | Updated: 1:36 am, Tue Jan 15, 2013.

(BPT) - Christmas Day 2012 will see Tim Daugherty back at the head of the dinner table where he belongs with his wife Debbie and their family in his hometown of Florence, Oregon. Two years ago, after an unexpected and frightening diagnosis during a routine medical exam, Tim, a 52-year-old fifth grade school teacher, wasn't sure he'd be around much longer to enjoy the simple pleasures of life with his wife of more than 30 years, their three grown children, and their two grandchildren.

Two years younger than Tim and married to him since she was 18-years-old, Debbie, a secretary at the local high school, has always looked after her husband. Tim is a dedicated school teacher who often gives all of his time and energy to his students. So it wasn’t unusual for Debbie to remind Tim to ask the doctor to perform a standard PSA test during his routine physical. Though he felt fine and had no symptoms, they were very surprised when the results from the test came back. His PSA was elevated and after a biopsy, Tim and Debbie learned he had aggressive prostate cancer.

“When I found out about Tim’s diagnosis of prostate cancer, I knew it was a challenge that we needed to overcome together,” said Debbie. “Tim is not the type to sit around and let something like this get him down; he is so full of energy and has such a strong passion for life, that he’ll do everything in his power to maintain our life together.”

Shortly after the diagnosis Tim underwent a prostatectomy and was put on hormone therapy. After several months, Tim’s PSA kept rising and they realized his cancer was continuing to grow. Knowing they’d need to fight this as a team, Debbie was committed to do whatever she could to help Tim during this difficult time. She continued to educate herself about Tim’s disease and his chances for survival. Through her never ending research efforts and communications with their local support group, she found out about PROVENGE®(sipuleucel-T), a breakthrough treatment option for certain men with advanced prostate cancer that uses immunotherapy to stimulate a patient’s own immune system to recognize the cancer cells in the body and attack them.

Shortly thereafter, the couple talked with Tim’s physician and found out he was eligible to receive the treatment. It was an exciting time for the both of them because this was another chance to help Tim fight the disease while possibly extending his life. Tim received his first infusion of PROVENGE in January 2012 and completed treatment by February.

“Tim is glad to have received the treatment and grateful he was able to take advantage of this opportunity,” said Debbie, “We‘re looking forward to spending the upcoming holidays with our loved ones.”

The weather on Christmas Day will likely be cold and rainy, typical for Florence, Oregon, but that won’t stop the high school sweethearts from celebrating the blessings of love and laughter for their family and their offspring -- particularly their 4-year-old granddaughter and 7-year-old grandson -- their pride and joy.  Debbie says she'll never take any of that for granted again. "Along with the finest medical treatment available, we have tremendous support from our local patient support group, our church and our family and friends. That counts for a lot," said Debbie.

For more information about advanced prostate cancer, please visit www.provenge.com  

 

PROVENGE Indication and Safety Information

PROVENGE is an autologous cellular immunotherapy for the treatment of asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.

PROVENGE can cause serious reactions including those resulting from the infusion of the drug, which occur within 1 day of infusion, and strokes. Severe infusion reactions can include chills, fever, fatigue, weakness, breathing problems, dizziness, headache, high blood pressure, muscle ache, nausea, and vomiting.

The most common side effects reported with PROVENGE in clinical trials were chills, fatigue, fever, back pain, nausea, joint ache and headache. These are not all the possible side effects of PROVENGE treatment. For more information, please talk with your doctor.

For full prescribing information, visit www.provenge.com or call Dendreon on call at 1-877-336-3736.

P-A-12.12-327.00

Rules of Conduct

  • 1 Use your real name. You must register with your full first and last name before you can comment. (And don't pretend you're someone else.)
  • 2 Keep it clean. Please avoid obscene, vulgar, lewd, racist or sexually oriented language.
  • 3 Don't threaten. Threats of harming another person will not be tolerated.
  • 4 Be truthful. Don't lie about anyone or anything. Don't post unsubstantiated allegations, rumors or gossip that could harm the reputation of a person, company or organization.
  • 5 Be nice. No racism, sexism or any sort of -ism that is degrading to another person.
  • 6 Stay on topic. Make sure your comments are about the story. Don't insult each other.
  • 7 Tell us if the discussion is getting out of hand. Use the 'Report' link on each comment to let us know of abusive posts.
  • 8 Share what you know, and ask about what you don't.

Welcome to the discussion.

    (%remaining%) Remaining Thanks for visiting Lodinews.com. You're entitled to view 20 free articles every 30 days. You will see 10 articles for free before being asked to register, and then you can view 10 additional articles by registering or logging in. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thanks for visiting Lodinews.com. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) free articles remaining ((%remaining_reg%) before being asked to register and (%remaining_sub%) before being asked to subscribe). Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thanks for visiting Lodinews.com. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) free articles remaining ((%remaining_reg%) before being asked to register and (%remaining_sub%) before being asked to subscribe). Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thanks for visiting Lodinews.com. You're entitled to view 20 free articles every 30 days, and you currently have (%remaining%) total free articles remaining ((%remaining_reg%) before being asked to register and (%remaining_sub%) before being asked to subscribe). Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thank you for reading Lodinews.com. You have viewed (%viewed%) of your 20 free pages in 30 days. Please login or register at this time and enjoy the next (%remaining%) articles free of charge. After your 20 free articles, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thank you for reading Lodinews.com. Because you have already viewed this article, you may view it again as many times as you would like without subtracting from your remaining free article views.
    (%remaining%) Remaining Thank you for registering on Lodinews.com. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thank you for reading Lodinews.com. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thank you for reading Lodinews.com. You're entitled to view 20 articles for free every 30 days, and you currently have (%remaining%) remaining. Then, if you enjoy our site and want full access, we'll ask you to purchase an affordable subscription.
    (%remaining%) Remaining Thank you for reading Lodinews.com. You're entitled to view 20 articles for free every 30 days. This is your last free article this period. On your next article we'll ask you to purchase an affordable subscription.

    Poll

    Loading…

    Regional News

    Mailing List

    Subscribe to a mailing list to have daily news sent directly to your inbox.

    • News Updates

      Would you like to receive our daily news headlines? Sign up now!

    Manage Your Lists